Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.
Li F, Liu B, Xiong Y, Zhang Z, Zhang Q, Qiu R, Peng F, Nian X, Wu D, Li X, Liu J, Li Z, Tu H, Wu W, Wang Y, Zhang J, Yang X. Li F, et al. Among authors: nian x. Vaccines (Basel). 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138. Vaccines (Basel). 2024. PMID: 38400122 Free PMC article.
Suspended cell lines for inactivated virus vaccine production.
Zhang J, Qiu Z, Wang S, Liu Z, Qiao Z, Wang J, Duan K, Nian X, Ma Z, Yang X. Zhang J, et al. Among authors: nian x. Expert Rev Vaccines. 2023 Jan-Dec;22(1):468-480. doi: 10.1080/14760584.2023.2214219. Expert Rev Vaccines. 2023. PMID: 37199282 Free article. Review.
Coping Strategies for Pertussis Resurgence.
Nian X, Liu H, Cai M, Duan K, Yang X. Nian X, et al. Vaccines (Basel). 2023 Apr 24;11(5):889. doi: 10.3390/vaccines11050889. Vaccines (Basel). 2023. PMID: 37242993 Free PMC article. Review.
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.
Huang X, Liang J, Huang L, Nian X, Chen W, Zhang J, Xu X, Lin X, Wang Y, Shi J, Jia L, Li Q, Wang Q, Duan K, Li X, Ji Y, Peng F, Zhang W, Xie Z, Wang Y, Yang X. Huang X, et al. Among authors: nian x. Hum Vaccin Immunother. 2023 Dec 31;19(1):2211896. doi: 10.1080/21645515.2023.2211896. Epub 2023 May 30. Hum Vaccin Immunother. 2023. PMID: 37249318 Free PMC article. Clinical Trial.
Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: A preclinical study.
Zhang J, Nian X, Liu B, Zhang Z, Zhao W, Han X, Ma Y, Jin D, Ma H, Zhang Q, Qiu R, Li F, Gong Z, Li X, Yang Y, Tian Y, Zhou L, Duan K, Li X, Ma Z, Yang X. Zhang J, et al. Among authors: nian x. Antiviral Res. 2023 Aug;216:105639. doi: 10.1016/j.antiviral.2023.105639. Epub 2023 Jun 1. Antiviral Res. 2023. PMID: 37270159 Free article.
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.
Fan R, Huang X, Nian X, Ou Z, Zhou J, Zhang J, Zeng P, Zhao W, Deng J, Chen W, Chen S, Duan K, Chen Y, Li X, Zhang J, Yang X. Fan R, et al. Among authors: nian x. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9. doi: 10.1080/21645515.2021.1967041. Epub 2021 Sep 2. Hum Vaccin Immunother. 2022. PMID: 34473607 Free PMC article. Clinical Trial.
125 results